Expert Highlights Areas of Research in MCL
Krish Patel, MD, discusses the areas of research he finds particularly interesting for the treatment of patients with mantle cell lymphoma.
Krish Patel, MD, an oncologist at the Swedish Cancer Institute, discusses the areas of research he finds particularly interesting for the treatment of patients with mantle cell lymphoma (MCL).
Moving forward, Patel thinks it will be interesting to see how CAR T-cell therapy evolves in this space. This is an exciting area of research for MCL, as well as the other lymphoid malignancies where these agents are also being investigated. However, it is too early to know the ultimate impact of this research.
Acalabrutinib/Obinutuzumab Shows Improved PFS in Treatment-Naive CLL
April 10th 2024In an interview with Targeted Oncology, Jeff Sharman, MD, discussed the results of the ELEVATE-TN trial of acalabrutinib with or without obinutuzumab at 74.5 months of follow-up among patients with chronic lymphocytic leukemia.
Read More
